Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-20 5:24 pm Purchase | 2023-12-18 | 13D | NEUROGENE INC NGNE | BAKER BROS. ADVISORS LP | 649,685 4.990% | 176,018 (+37.16%) | Filing History |
| 2023-12-18 5:25 pm Sale | 2023-12-14 | 13D | SEAGEN INC SGEN | BAKER BROS. ADVISORS LP | 0 0.000% | -45,074,469 (Position Closed) | Filing History |
| 2023-12-15 5:20 pm Purchase | 2023-12-15 | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,744,669 11.400% | 467,102 (+14.25%) | Filing History |
| 2023-12-13 4:55 pm Purchase | 2023-12-11 | 13D | PRELUDE THERAPEUTICS INC PRLD | BAKER BROS. ADVISORS LP | 10,222,968 24.300% | 3,888 (+0.04%) | Filing History |
| 2023-11-24 1:43 pm Purchase | 2023-11-21 | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,365,472 19.990% | 167,553 (+7.62%) | Filing History |
| 2023-11-21 5:24 pm Sale | 2023-11-17 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,987,702 9.990% | -28,058 (-1.39%) | Filing History |
| 2023-11-14 5:18 pm Sale | 2023-11-14 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | BAKER BROS. ADVISORS LP | 138,678,037 13.000% | -14,300,000 (-9.35%) | Filing History |
| 2023-11-13 4:22 pm Purchase | 2023-10-31 | 13G | CERUS CORP CERS | BAKER BROS. ADVISORS LP | 19,101,876 10.500% | 3,014,454 (+18.74%) | Filing History |
| 2023-10-10 4:42 pm Purchase | 2023-10-05 | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 473,667 19.990% | 62 (+0.01%) | Filing History |
| 2023-10-05 4:36 pm Purchase | 2023-10-03 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,015,760 9.990% | 470,647 (+30.46%) | Filing History |
| 2023-08-17 5:12 pm Sale | 2023-08-15 | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 473,605 19.990% | -28,549 (-5.69%) | Filing History |
| 2023-08-10 4:42 pm Sale | 2023-07-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | BAKER BROS. ADVISORS LP | 14,604,391 2.200% | -54,754,968 (-78.94%) | Filing History |
| 2023-08-10 4:39 pm Sale | 2023-07-31 | 13G | VERASTEM INC VSTM | BAKER BROS. ADVISORS LP | 0 0.000% | -1,345,192 (Position Closed) | Filing History |
| 2023-08-08 5:16 pm Unchanged | 2023-08-07 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.400% | 0 (Unchanged) | Filing History |
| 2023-07-19 5:28 pm Purchase | 2023-07-17 | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 502,154 19.990% | 290,663 (+137.44%) | Filing History |
| 2023-06-28 5:01 pm Purchase | 2023-06-22 | 13D | IGM BIOSCIENCES INC IGMS | BAKER BROS. ADVISORS LP | 3,277,567 9.990% | 107,673 (+3.40%) | Filing History |
| 2023-06-16 7:18 pm Unchanged | 2023-06-15 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.400% | 0 (Unchanged) | Filing History |
| 2023-06-12 4:37 pm Sale | 2023-05-31 | 13G | VERASTEM INC VSTM | BAKER BROS. ADVISORS LP | 1,345,192 8.000% | -903,883 (-40.19%) | Filing History |
| 2023-06-02 4:06 pm Purchase | 2023-05-25 | 13D | TSCAN THERAPEUTICS INC TCRX | BAKER BROS. ADVISORS LP | 2,793,938 6.500% | 9,146 (+0.33%) | Filing History |
| 2023-05-24 5:11 pm Purchase | 2023-05-23 | 13D | ACADIA PHARMACEUTICALS INC ACAD | BAKER BROS. ADVISORS LP | 43,227,599 26.500% | 920,810 (+2.18%) | Filing History |